Momentum Stocks Try To Beat Analysts’ Views: KKR & Co. (NYSE:KKR), Cousins Properties (NYSE:CUZ)

Shares of KKR & Co. L.P. (NYSE:KKR) [Trend Analysis] runs in leading trade, it plunging -0.18% to traded at $17.11. The firm has price volatility of 2.90% for a week and 2.57% for a month. Its beta stands at 1.62 times. Lets us look over what analysts have to say about performance of the KKR. Starting with EPS for the final quarter of this year. EPS is usually the indicator of profitability for the company. According to WSJ analysis, the Q4 2016 current estimates trends were for $0.50 as compared to the next year Q1 current trend of $0.49. While on annual basis the current EPS estimates trend for FY 2017 came in for $2.08 as compared to three months ago $2.05.

The stock prices target chart showed high target of 25 kept by analysts at WSJ while the average price target was for 19.04 as compared to current price of 17.11. Somehow, the stock managed to gain BUY ratings by 11 analyst in current tenure as 1 analyst having overweight ratings, 5 recommend as HOLD, no one gave it as a SELL security for current period. Overall, the consensus ratings were for Overweight by the pool of analysts.

Narrow down four to firm performance, its weekly performance was 11.37% and monthly performance was 4.90%. The stock price of KKR is moving up from its 20 days moving average with 4.28% and isolated positively from 50 days moving average with 10.10%.

Cousins Properties Incorporated (NYSE:CUZ) [Trend Analysis] luring active investment momentum, shares a decrease remains unchanged to $8.36. Finally to see some strong financial remarks by WSJ over CUZ performance. Out of the pool of analysts 1 gave their BUY ratings on the stock in previous month as 1 analyst having BUY in current month. The stock was ranked as Underweight by 1 analyst while 1 analyst gave SELL rank. Majority ranked Hold from the pool of analysts.

The next year first quarter EPS estimates trend for current period shows $0.02 while one month ago this estimate trend was for $0.02. EPS indicator shows the robustness of the stock and its analysis opens up the clear picture of company’s profitability. On annual basis of EPS, FY 2017 Estimate Trends at current were for $0.11 and for the one month was for $0.11. Whereas, CUZ received highest price target of 9 and low target of 8. The stock price target chart showed average price target of 8.50 as compared to current price of 8.36.

The total volume of 2.06 Million shares held in the session was surprisingly higher than its average volume of 3756.87 shares. EPS estimates indicating constrictive facts, the current year from sell-side analysts, Price to current year EPS stands at 390%, and looking further price to next year’s EPS is -45%. While take a short look on price to sales ratio, that was 8.79 and price to earnings ratio of 17.86 attracting passive investors.


About Gerard Bergeron

Gerard Bergeron covers Bio-pharmacy or healthcare sector Press Releases news updates. He has extensive three year of experience in content writing as freelance writer. He performs analysis of Healthcare Companies and provides worthy information for investor community. He is an experienced writer with a precise grasp of the English language and a clear, compelling writing style.

Leave a Reply

Your email address will not be published. Required fields are marked *